NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

nCino Beats on Q2 but Shares Drop as Guidance Falls Short of Growth Expectations

nCino beat Q2 on revenue, margins and cash flow, but modest full-year guidance and in-line Q3 outlook lack the growth acceleration expected.

nCino Beats on Q2 but Shares Drop as Guidance Falls Short of Growth Expectations
Credit: nCino
Already have an account? Sign in.
08/25/2026 · 5:27 PM
NCNO
/ Don’t stop at just one post.

Related↓

nCino Stock Surges After Profits More Than Double and Full-Year Guidance Raised
05/28/2026 · 6:41 AM

nCino Stock Surges After Profits More Than Double and Full-Year Guidance Raised

nCino beat expectations, raised outlook, and saw strong growth, sending its stock up as investors regained confidence in its AI banking platform.

/ Subscriber only
/ Read more

Feed↓

Instacart in Preliminary Talks for Potential Sale, DoorDash and Uber Involved
Featured/ 10/23/2026 · 4:22 PM

Instacart in Preliminary Talks for Potential Sale, DoorDash and Uber Involved

Instacart is exploring a sale that could value the company at $16–17 billion, with preliminary talks involving DoorDash and Uber.

/ Subscriber only
Scotiabank Sees Bargain in AST SpaceMobile After 70% Drop, Upgrades Stock
Featured/ 10/23/2026 · 3:41 PM

Scotiabank Sees Bargain in AST SpaceMobile After 70% Drop, Upgrades Stock

Analysts upgrade AST SpaceMobile to Outperform after a sharp drop. Scotiabank cites SpaceX competition but sees value in AST’s wholesale 5G model.

/ Subscriber only
Corcept Faces New Competitive Pressure as Genmab’s Rina-S Shows Broad Benefit in Platinum-Resistant Ovarian Cancer
10/23/2026 · 2:44 PM

Corcept Faces New Competitive Pressure as Genmab’s Rina-S Shows Broad Benefit in Platinum-Resistant Ovarian Cancer

Rina-S shows significant PFS and OS gains in platinum-resistant ovarian cancer, challenging Corcept’s Lifyorli position.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI